Articles

  • 1 week ago | oncologynewscentral.com | Carina Storrs |Youssef Rddad

    More work is needed to adequately address sexual and reproductive toxicity in patients receiving treatment for cancer, according to a comment recently published in Lancet Oncology. David J. Benjamin, MD, of the Hoag Family Cancer Institute in Newport Beach, California, and Mark P.

  • 1 week ago | oncologynewscentral.com | Harsha Vyas |Rebecca Johnson |Carina Storrs |Samyukta Mullangi

    An analysis of EHR metadata from 2019 to 2022 found that the number of EHR messages for oncologists grew by 19.0%, with medical oncology hit the hardest. These findings, published in JNCI: Journal of the National Cancer Institute, emphasize the need for health systems to implement approaches that help reduce oncologists’ EHR burden, experts say. “Otherwise, we’re going to lose a really valuable modality for patients and clinicians to communicate in a way they previously wouldn’t have.

  • 2 weeks ago | oncologynewscentral.com | Carina Storrs

    Sara Carton, RN, a Minneapolis-based hematology-oncology nurse, is used to creating deep, meaningful connections with patients. She has worked in cancer care since her graduation in 2018. Although vastly different, there are parallels between her career in oncology and the emotionally charged, high-stakes environment of Netflix’s Love Is Blind. Carton, who got hooked on the reality television series during its first season in 2020, found herself drawn to it.

  • 3 weeks ago | states.aarp.org | Carina Storrs

    A man posing as a bank employee stole $40,000 in cash from an 84-year-old woman in a Detroit suburb several months ago. The case captured media attention because local police — alerted by the woman’s daughters — caught the suspect as he arrived at her doorstep to take another $25,000. It is one of many stories of fraud that regularly appear on the local TV news, says Brenda Price, an AARP Michigan associate state director for community outreach.

  • 3 weeks ago | oncologynewscentral.com | Carina Storrs |Emily Bader |Youssef Rddad

    On March 28, the U.S. Food and Drug Administration (FDA) expanded the indication for lutetium Lu 177 vipivotide tetraxetan (Pluvicto) to include adults with prostate-specific membrane antigen (PSMA)-positive metastatic castration-resistant prostate cancer (mCRPC) who have undergone prior androgen receptor pathway inhibition (ARPI) therapy and can postpone taxane-based chemotherapy.

Contact details

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →

X (formerly Twitter)

Followers
1K
Tweets
1K
DMs Open
No
Carina Storrs
Carina Storrs @cstorrs
29 Sep 23

!!

Gus Saltonstall
Gus Saltonstall @GusSaltonstall

The Central Park Zoo Sea Lion enclosure/pool has flooded and the sea lion's are swimming around the entirety of the space. https://t.co/oLYVPWWw00

Carina Storrs
Carina Storrs @cstorrs
14 Sep 23

RT @brittwray: Do you work in higher education as faculty or staff? This week, @DrKWilkinson from @allwecansave has unveiled a transformati…

Carina Storrs
Carina Storrs @cstorrs
14 Sep 23

I personally find "data dumping" especially galling in interviews. Reading about the tactics of a master dumper, Kennedy, will help me think of some better counterstrategies, I hope https://t.co/uH85KLBSox...